Tratamiento laparoscópico de tres pacientes con tumores neuroendócrinos gástricos.: Reporte de casos

Martín Varela Vega; Leticia Barro; Sofía Baranov; Agustina Da Rosa; Gabriela Larrosa; Santiago Cubas; Gerardo Beraldo; Pablo Santiago

doi:10.31837/cir.urug.5.1.6

Authors

Martín Varela Vega Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0003-2376-2844
Leticia Barro Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay. https://orcid.org/0000-0001-6940-0342
Sofía Baranov Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0002-1914-3285
Agustina Da Rosa Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0002-7313-1306
Gabriela Larrosa Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0003-1725-5096
Santiago Cubas Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0001-6026-5316
Gerardo Beraldo Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0002-3311-160X
Pablo Santiago Seccional de Cirugía Esófago Gástrica y Bariátrica. Hospital Central de las Fuerzas Armadas. Montevideo, Uruguay https://orcid.org/0000-0002-7733-8291

DOI:

https://doi.org/10.31837/cir.urug.5.1.6

Keywords:

gastric tumors, gastric surgery, surgical treatment

Abstract

Gastric neuroendocrine tumors constitute 6.9% of all gastrointestinal neuroendocrine tumors and approximately 1% of all gastric neoplasms. They comprise a wide group of tumors that may or may not be secreting, and with very different biological behavior. Although most of them are benign, a small percentage have an aggressive behavior, with metastatic capacity and a poor survival. Given its relatively indolent course, sometimes the diagnosis results from a fortuitous finding, or less commonly when a complication (hemorrhage or obstruction) arises. Upper endoscopy with immunohistochemical analysis of the biopsy is essential for diagnosis. Tomography is the choice for staging. Lymph node dissemination is rare, and lymphatic emptying is not indicated except in cases of undifferentiated tumors or with visible lymphadenopathy intraoperatively, so the laparoscopic approach is especially attractive. The objective of this communication is to present three cases of laparoscopic resolution of gastric neuroendocrine tumors in our department.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

1. Siegel R, Miller K, Jemal A. Cancer statistics. CA Cancer J Clin . 2017;67(1):7-30 doi: 10.3322/caac.21387
2. Sciuto, Pablo y col. Tumores neuroendócrinos del tubo digestivo y páncreas, enfoque quirúrgico. Montevideo: Ediciones de la Plaza, 2015.
3. Connor JM, Marmissolle F, Bestani C, Pesce V, Belli S, Dominichini E. Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study. Mol Clin Oncol 2014; 2(5):673-84. doi: 10.3892/mco.2014.332
4. Neuroendocrine and Adrenal Tumors. Version 1.2019. In: National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines). Disponible en: https://arupconsult.com/reference/nccn-neuroendocrine-and-adrenal-tumors-version-12019
5. DelleFave G, Kwekkeboom DJ, Van Cutsem E, Rindi G, Kos-Kudla B, Knigge U et al. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms. Neuroendocrinology 2012; 95:74–87. doi: 10.1159/000335595
6. Young Kim J, Hong SM, Y. Ro J. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol 2017;29:11–6. doi: 10.1016/j.anndiagpath.2017.04.005
7. Klöppel, G., Couvelard, A., Perren, A., Komminoth, P., McNicol, A.-M., Nilsson, O, et al.. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification. Neuroendocrinology, 2009;90(2):162–6. doi: 10.1159/000182196
8. Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. Current Status of Gastrointestinal Carcinoids. Gastroenterology 2005;128(6):1717–51. doi:10.1053/j.gastro.2005.03.038
9. Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, et al. Consensus guidelines for the management and treatment of neuroendocrine tumours. Pancreas. 2013;42(4):557-77
10. Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V, et bal. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9(1): 61–72. doi:10.1016/s1470-2045(07)70410-2.
11. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13 715 carcinoid tumors. Cancer 2003; 97: 934–59. doi: 10.1002/cncr.11105.
12. Sorbye, H., Strosberg, J., Baudin, E., Klimstra, D. S., & Yao, J. C. (2014). Gastroenteropancreatic high-grade neuroendocrine carcinoma. Cancer 2014; 120(18): 2814–23. doi: 10.1002/cncr.28721
13. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J V Interv Radiol 2006;17(8):1235–49. doi: 10.1097/01.RVI.0000232177.57950.71.
14. Kwekkeboom DJ, de Herder WW, Kam BL, van Eijck CH, van Essen M, Kooij PP, et al. Treatment with the radiolabeled somatostatin analog J Clin Oncol. 2008;26(13):2124–30 doi: 10.1200/JCO.2007.15.2553.